Sustained and Efficient Delivery of Antivascular Endothelial Growth Factor by the Adeno-associated Virus for the Treatment of Corneal Neovascularization: An Outlook for Its Clinical Translation
Corneal diseases represent 5.1% of all eye defects and are the fourth leading cause of blindness globally. Corneal neovascularization can arise from all conditions of chronic irritation or hypoxia, which disrupts the immune-privileged state of the healthy cornea, increases the risk of rejection afte...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-01-01
|
| Series: | Journal of Ophthalmology |
| Online Access: | http://dx.doi.org/10.1155/2024/5487973 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832542994703581184 |
|---|---|
| author | Mengzhen Xie Lixiang Wang Yingping Deng Ke Ma Hongbo Yin Xiaolan Zhang Xingye Xiang Jing Tang |
| author_facet | Mengzhen Xie Lixiang Wang Yingping Deng Ke Ma Hongbo Yin Xiaolan Zhang Xingye Xiang Jing Tang |
| author_sort | Mengzhen Xie |
| collection | DOAJ |
| description | Corneal diseases represent 5.1% of all eye defects and are the fourth leading cause of blindness globally. Corneal neovascularization can arise from all conditions of chronic irritation or hypoxia, which disrupts the immune-privileged state of the healthy cornea, increases the risk of rejection after keratoplasty, and leads to opacity. In the past decades, significant progress has been made for neovascular diseases of the retina and choroid, with plenty of drugs getting commercialized. In addition, to overcome the barriers of the short duration and inadequate penetration of conventional formulations of antivascular endothelial growth factor (VEGF), multiple novel drug delivery systems, including adeno-associated virus (AAV)-mediated transfer have gone through the full process of bench-to-bedside translation. Like retina neovascular diseases, corneal neovascularization also suffers from chronicity and a high risk of recurrence, necessitating sustained and efficient delivery across the epithelial barrier to reach deep layers of the corneal stroma. Among the explored methods, adeno-associated virus-mediated delivery of anti-VEGF to treat corneal neovascularization is the most extensively researched and most promising strategy for clinical translation although currently although, it remains predominantly at the preclinical stage. This review comprehensively examines the necessity, benefits, and risks of applying AAV vectors for anti-VEGF drug delivery in corneal vascularization, including its current progress and challenges in clinical translation. |
| format | Article |
| id | doaj-art-17c86324f15742cd80ded610a838f012 |
| institution | Kabale University |
| issn | 2090-0058 |
| language | English |
| publishDate | 2024-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Ophthalmology |
| spelling | doaj-art-17c86324f15742cd80ded610a838f0122025-02-03T11:56:02ZengWileyJournal of Ophthalmology2090-00582024-01-01202410.1155/2024/5487973Sustained and Efficient Delivery of Antivascular Endothelial Growth Factor by the Adeno-associated Virus for the Treatment of Corneal Neovascularization: An Outlook for Its Clinical TranslationMengzhen Xie0Lixiang Wang1Yingping Deng2Ke Ma3Hongbo Yin4Xiaolan Zhang5Xingye Xiang6Jing Tang7Department of OphthalmologyDepartment of OphthalmologyDepartment of OphthalmologyDepartment of OphthalmologyDepartment of OphthalmologyDepartment of OphthalmologySchool of Life Science and EngineeringDepartment of OphthalmologyCorneal diseases represent 5.1% of all eye defects and are the fourth leading cause of blindness globally. Corneal neovascularization can arise from all conditions of chronic irritation or hypoxia, which disrupts the immune-privileged state of the healthy cornea, increases the risk of rejection after keratoplasty, and leads to opacity. In the past decades, significant progress has been made for neovascular diseases of the retina and choroid, with plenty of drugs getting commercialized. In addition, to overcome the barriers of the short duration and inadequate penetration of conventional formulations of antivascular endothelial growth factor (VEGF), multiple novel drug delivery systems, including adeno-associated virus (AAV)-mediated transfer have gone through the full process of bench-to-bedside translation. Like retina neovascular diseases, corneal neovascularization also suffers from chronicity and a high risk of recurrence, necessitating sustained and efficient delivery across the epithelial barrier to reach deep layers of the corneal stroma. Among the explored methods, adeno-associated virus-mediated delivery of anti-VEGF to treat corneal neovascularization is the most extensively researched and most promising strategy for clinical translation although currently although, it remains predominantly at the preclinical stage. This review comprehensively examines the necessity, benefits, and risks of applying AAV vectors for anti-VEGF drug delivery in corneal vascularization, including its current progress and challenges in clinical translation.http://dx.doi.org/10.1155/2024/5487973 |
| spellingShingle | Mengzhen Xie Lixiang Wang Yingping Deng Ke Ma Hongbo Yin Xiaolan Zhang Xingye Xiang Jing Tang Sustained and Efficient Delivery of Antivascular Endothelial Growth Factor by the Adeno-associated Virus for the Treatment of Corneal Neovascularization: An Outlook for Its Clinical Translation Journal of Ophthalmology |
| title | Sustained and Efficient Delivery of Antivascular Endothelial Growth Factor by the Adeno-associated Virus for the Treatment of Corneal Neovascularization: An Outlook for Its Clinical Translation |
| title_full | Sustained and Efficient Delivery of Antivascular Endothelial Growth Factor by the Adeno-associated Virus for the Treatment of Corneal Neovascularization: An Outlook for Its Clinical Translation |
| title_fullStr | Sustained and Efficient Delivery of Antivascular Endothelial Growth Factor by the Adeno-associated Virus for the Treatment of Corneal Neovascularization: An Outlook for Its Clinical Translation |
| title_full_unstemmed | Sustained and Efficient Delivery of Antivascular Endothelial Growth Factor by the Adeno-associated Virus for the Treatment of Corneal Neovascularization: An Outlook for Its Clinical Translation |
| title_short | Sustained and Efficient Delivery of Antivascular Endothelial Growth Factor by the Adeno-associated Virus for the Treatment of Corneal Neovascularization: An Outlook for Its Clinical Translation |
| title_sort | sustained and efficient delivery of antivascular endothelial growth factor by the adeno associated virus for the treatment of corneal neovascularization an outlook for its clinical translation |
| url | http://dx.doi.org/10.1155/2024/5487973 |
| work_keys_str_mv | AT mengzhenxie sustainedandefficientdeliveryofantivascularendothelialgrowthfactorbytheadenoassociatedvirusforthetreatmentofcornealneovascularizationanoutlookforitsclinicaltranslation AT lixiangwang sustainedandefficientdeliveryofantivascularendothelialgrowthfactorbytheadenoassociatedvirusforthetreatmentofcornealneovascularizationanoutlookforitsclinicaltranslation AT yingpingdeng sustainedandefficientdeliveryofantivascularendothelialgrowthfactorbytheadenoassociatedvirusforthetreatmentofcornealneovascularizationanoutlookforitsclinicaltranslation AT kema sustainedandefficientdeliveryofantivascularendothelialgrowthfactorbytheadenoassociatedvirusforthetreatmentofcornealneovascularizationanoutlookforitsclinicaltranslation AT hongboyin sustainedandefficientdeliveryofantivascularendothelialgrowthfactorbytheadenoassociatedvirusforthetreatmentofcornealneovascularizationanoutlookforitsclinicaltranslation AT xiaolanzhang sustainedandefficientdeliveryofantivascularendothelialgrowthfactorbytheadenoassociatedvirusforthetreatmentofcornealneovascularizationanoutlookforitsclinicaltranslation AT xingyexiang sustainedandefficientdeliveryofantivascularendothelialgrowthfactorbytheadenoassociatedvirusforthetreatmentofcornealneovascularizationanoutlookforitsclinicaltranslation AT jingtang sustainedandefficientdeliveryofantivascularendothelialgrowthfactorbytheadenoassociatedvirusforthetreatmentofcornealneovascularizationanoutlookforitsclinicaltranslation |